(0.00%) 5 187.67 points
(0.44%) 39 056 points
(-0.18%) 16 303 points
(1.06%) $79.21
(-1.09%) $2.18
(-0.33%) $2 316.60
(0.07%) $27.56
(-0.30%) $985.45
(0.11%) $0.931
(0.05%) $10.90
(0.11%) $0.800
(0.18%) $91.61
-1.57% $ 2.50
@ $1.790
Wydano: 14 vas. 2024 @ 16:30
Zwrot: 39.66%
Poprzedni sygnał: vas. 13 - 16:30
Poprzedni sygnał:
Zwrot: 1.71 %
Live Chart Being Loaded With Signals
Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate population of T cells with durable stemness...
Stats | |
---|---|
Dzisiejszy wolumen | 839 769 |
Średni wolumen | 901 873 |
Kapitalizacja rynkowa | 637.35M |
EPS | $0 ( 2024-05-02 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -2.78 |
ATR14 | $0.00300 (0.12%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-02-09 | Lang Matthew | Buy | 500 000 | Option (right to buy) |
2024-02-09 | Lang Matthew | Buy | 50 000 | Common Stock |
2024-02-09 | Hill Stephen J. | Buy | 400 000 | Stock Option (right to buy) |
2024-02-09 | Hill Stephen J. | Buy | 40 000 | Common Stock |
2024-02-09 | Lee Gary K. | Buy | 400 000 | Stock Option (right to buy) |
INSIDER POWER |
---|
39.57 |
Last 94 transactions |
Buy: 113 687 542 | Sell: 91 558 207 |
Wolumen Korelacja
Lyell Immunopharma, Inc. Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Lyell Immunopharma, Inc. Korelacja - Waluta/Towar
Lyell Immunopharma, Inc. Finanse
Annual | 2023 |
Przychody: | $130 000 |
Zysk brutto: | $-20.12M (-15 476.92 %) |
EPS: | $-0.930 |
FY | 2023 |
Przychody: | $130 000 |
Zysk brutto: | $-20.12M (-15 476.92 %) |
EPS: | $-0.930 |
FY | 2022 |
Przychody: | $84.68M |
Zysk brutto: | $68.22M (80.55 %) |
EPS: | $-0.0192 |
FY | 2021 |
Przychody: | $10.65M |
Zysk brutto: | $10.65M (100.00 %) |
EPS: | $-1.249 |
Financial Reports:
No articles found.
Lyell Immunopharma, Inc.
Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate population of T cells with durable stemness. Its pipeline includes LYL797, a T cell product candidate for the treatment of non-small cell lung cancer and triple negative breast cancers; LYL845, that targets multiple solid tumors; and NY-ESO-1 for synovial sarcoma and other solid tumor indications. The company entered into research and development collaboration and license agreement with GlaxoSmithKline for NY-ESO-1 program. Lyell Immunopharma, Inc. was incorporated in 2018 and is headquartered in South San Francisco, California.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej